Market Tracker

10/21 11:10am ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

5.40
Data as of 10:53am ET
 -0.09 / -1.64%
Today’s Change
5.01
Today|||52-Week Range
53.40
-51.35%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close5.49
Today’s open5.42
Day’s range5.40 - 5.42
Volume1,586
Average volume (3 months)21,991
Market cap$71.0M
Dividend yield--
Data as of 10:53am ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+93.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratio1.7
Price/Sales1.73
Price/Book1.01

Competitors

 Today’s
change
Today’s
% change
IMMYImprimis Pharmaceuti...+0.03+0.37%
MSTXMast Therapeutics In...-0.01-0.92%
ARQLArQule Inc-0.02-1.68%
ASTMAastrom Biosciences ...+0.00+0.06%
Data as of 10:55am ET, 10/21/2014

Financials

Last reporting dateAugust 6, 2014
EPS forecast (this quarter)$1.25
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts